维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Wolanskyj"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The interaction between leuko- cytosis and other risk factors for thrombosis in essential thrombo- cythemia显示文摘	Tefferi A Gangat N Wolanskyj A	2007	Blood2007，109，9：	1
2	JAK2 mutation in essential thrombocythaemia: clinical associations and long- term prognostic relevance显示文摘	Wolanskyj AP Lasho TL Schwager SM	2005	Br J Haematol2005，131，2：	1
3	Essential thrombocythemia beyond the first decade:life expectancy,longterm complication rates,and prognostic factors显示文摘	Wolanskyj AP Schwager SM McClure RF	2006	Mayo Clin Proc2006，81，2：	1
4	Management of extreme thrombocytosis in otherwise low-risk essential thrombocythemia; does number matter?显示文摘	Tefferi A Gangat N Wolanskyj AP	2006	Blood2006，108，7：	1
5	Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera显示文摘	Gangat N Wolanskyj AP Schwager SM	2009	Cancer2009，115，24：	1
6	Risk stratification for survival and leukemic transformation in essential thrombocythemia: A single institutional study of 605 patients 显示文摘	Gangat N Wolanskyj AP McClure RF	2007	Leukemia2007，21，2：	1
7	JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance显示文摘	Wolanskyj AP Lasho TL Schwager SM	2005	Br J Haematol2005，131，2：	1
8	Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients 显示文摘	Gangat N Wolanskyj AP McClure RF	2007	Leukemia2007，21，2：	1
9	JAK2 mutation in essential thrombocythaemia:clinical associations and long-term prognostic relevance显示文摘	Wolanskyj AP LashoTL Schwager SM		0，，：	1
10	JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance 显示文摘	Wolanskyj A P Lasho T L Schwager S M	2005	Br J Haematol2005，131，2：	1
11	JAK2 mutation in es- sential thrombocythaemia: clinical associations and long-term prog- nostic relevance 显示文摘	Wolanskyj AP Lasho TL Sehwager SM	2005	Br J Haematol2005，131，2：	1
12	JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance 显示文摘	Wolanskyj A P Lasho T L Schwager S M	2005	Br J Haematol2005，131，2：	1
13	A phase Ⅱ study of CC-5013 treatment for myelofibrosis with myeloid metaplasia:a preliminary report显示文摘	TEFFERI A HOGAN WJ WOLANSKYJ AP	2004	Blood2004，104，11：	1
14	Risk stratification for survival and leukemic transformation in essential thrombocythemia:a single institutional study of 605 patients显示文摘	Gangat N Wolanskyj A P McClure R F	2007	Leukemia2007，21，2：	1
15	JAK2 mutation in essential thrombocythaemia: clinical associations and long- term prognostic relevance 显示文摘	Wolanskyj AP Lasho TL Schwager SM	2005	Br J Haematol2005，131，2：	1
16	Anemia of chronic disease显示文摘	Gangat N Wolanskyj A P		0，，3：	1
17	Lack of efficacy of pyridoxine(Vitamin B6)treatment in acquired idiopathic sideroblastic anaemia,including refractory anaemia with ring sideroblasts显示文摘	Baumann Kreuziger LM Wolanskyj AP Hanson CA	2011	Eur J Haematol2011，86，：	1
18	Neutrophil PRV-1 mRNA expression across the chronic myeloproliferative disorders and in secondary or spurious polyeythemia显示文摘	Tefferi A Lasho TL Wolanskyj AP	2004	Blood2004，103，9：	1
19	JAK2 mutation in essential thrombcythaemia:clinical associations and long-term prognostic relevance显示文摘	Wolanskyj AP Lasho TL Schwagers M	2005	Br J Haematol2005，131，5：	1
20	FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature显示文摘	A. Pardanani R.P. Ketterling C.-Y. Li M.M. Patnaik A.P. Wolanskyj M.A. Elliott J.K. Camoriano J.H. Butterfield G.W. Dewald A. Tefferi	2005	Leukemia Research2005，，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示